Knowledge, Attitude and Practice of Community Pharmacists towards Adverse Drug Reactions Reporting

Easwaran, Vigneshwaran; Harichandana, Veluru; Sadiq, Mantargi Mohammed Jaffar; Alavudeen, Sirajudeen Shaik; Khan, Noohu Abdulla; Ahmed, Tajmulla

doi:10.5530/jyp.2020.12.15

Cited by 7 publications

(5 citation statements)

References 24 publications

(30 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study found that community pharmacists’ knowledge and attitudes toward diabetes care and management improved significantly following the educational session. Similar outcomes have been reported in Croatia and India, where the clinical expertise of community pharmacists increased following an interactive clinical pharmacy workshop [ 17 , 18 ].…”

Section: Discussionsupporting

confidence: 75%

Impact of an educational program on community pharmacist’s preparedness to conduct pharmacist-led diabetes clinic in Saudi Arabia

Rasheed

Hasan

Alqasoumi

et al. 2023

J of Pharm Policy and Pract

View full text Add to dashboard Cite

Background Demand for diabetes care and prevention has increased due to Saudi Arabia’s high prevalence of diabetes mellitus and its insufficient treatment. This raised awareness of the significance of community pharmacists in Saudi Arabia, who may significantly improve diabetes treatment by setting up pharmacist-led diabetic clinics. Thus, to assess community pharmacists’ readiness to lead diabetes clinics in Saudi Arabia, this study evaluated the usefulness of an educational session on diabetes care. Method The preparation of community pharmacists for diabetes treatment and management was assessed using a validated diabetes-specific questionnaire. An engaging and thorough diabetes education class was presented by two licensed diabetes educators. One-way ANOVA, chi-square, and the Mann–Whitney U-test were used to statistically assess the pre- and post-knowledge and attitude scores of community pharmacists. Results Following a learning session, the community pharmacists had a significant increase in understanding oral hypoglycemic medicines, monitoring the disease’s course, and dosing of insulin for diabetics (p = 0.01). Additionally, the community pharmacist’s perspective and attitude score on managing diabetes increased from 49.74 to 52.74 (p = 0.01). Conclusion The study’s findings demonstrated a marked improvement in community pharmacist’s knowledge of and attitude toward running pharmacist-led diabetic clinics following a session on diabetes education in collaboration with the Pharmacy College. The study’s findings also emphasized the significance of developing a structured programme for diabetes education in Saudi Arabia to address the demands of community pharmacists in terms of professional development.

show abstract

Section: Discussionsupporting

confidence: 75%

Impact of an educational program on community pharmacist’s preparedness to conduct pharmacist-led diabetes clinic in Saudi Arabia

Rasheed

Hasan

Alqasoumi

et al. 2023

J of Pharm Policy and Pract

View full text Add to dashboard Cite

show abstract

“…This finding is similar to that of other studies on the same topic in developing countries, demonstrating that this area still requires improvement. [4][5][6]8,19 No significant statistical differences were found in the results of the total KAP score among health professionals, However, some particular groups stood out, which could be further investigated in future studies.…”

Section: Discussionmentioning

confidence: 99%

Assessment of Knowledge, Attitude, and Practice of Pharmacovigilance among Healthcare Professionals in Brazil

Melo¹,

Duarte²,

Ferreira³

et al. 2020

JYP

View full text Add to dashboard Cite

Background: Adverse Drug Events represent a public health problem with high morbidity and mortality rates around the world. Knowledge, attitudes and practices of health professionals toward pharmacovigilance and reporting these events are important factors to promote safe drug therapy use. Objectives: The aim of this study was to evaluate Knowledge, attitudes and practices of health professionals and reporting of Adverse Drug Events by health professionals in Brazil. Methods: across-sectional study with a pretested questionnaire available online on the website of the Brazilian drug regulatory agency. Pharmacovigilance related Knowledge, attitudes and practices and Adverse Drug Events reporting were evaluated and correlations were estimated. Results: In total, 761health professionals responded to the survey. The overall knowledge, attitudes and practices was of 57.7% for pharmacists, 56.9% for nurses and 40% for physicians 40% (considered to be a poor level). When evaluating performance by region, one physician (100%) from the South region and one nurse from the Central-West (83.3%) performed well on this indicator. Professionals in the age group older than 45 years and those with postgraduate degrees had the best performance in knowledge, attitudes and practices. The statistical analysis was performed with the software State version 15. Conclusion: The study identified knowledge, attitudes and practices deficiencies in pharmacovigilance and mapped its main weaknesses, which makes it possible to better delineate measures to address these challenges and improve the Brazilian national pharmacovigilance system.

show abstract

“…Incentive payment schemes, legally-required reporting or use of reporting as a quality indicator in the GPs' contracts have been suggested so as to improve ADR reporting rates (114), however, none of them have succeeded to do so in many countries (43). Several studies suggest active training and educational interventions for HCPs on pharmacovigilance may improve their attitude and knowledge of ADR identification and reporting (115)(116)(117). Pharmacists are wellpositioned to identify and report ADRs (43, 118-120) and the quality of ADR reports submitted by both community and hospital pharmacists have been found to be comparable to reports from hospital doctors (121)(122)(123)(124).…”

Section: Figure 3 Endocrine System A) Antidiabetic Drugs (Biguanides ...mentioning

confidence: 99%

A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England

MOKBEL

Daniels

Weedon

et al. 2022

In Vivo

View full text Add to dashboard Cite

Background/Aim: Adverse drug reactions (ADRs) represent a major concern leading to significant increases in both morbidity and mortality globally. Providing healthcare professionals (HCPs) and patients with real-world data on drug safety is imperative to facilitate informed decisionmaking. The study aimed to determine the feasibility of creating comparative safety charts for medicines by mapping ADR reporting onto prescribing data. Materials and Methods: Data on serious and fatal ADR reports from the Yellow Card database was mapped onto general practice prescription data in England. The rate of serious and fatal ADR reports per million items prescribed was calculated for commonlyprescribed medicines. Results: Quantitative comparative analyses for 137 medicines belonging to 26 therapeutic classes were conducted. Significant differences were observed within most therapeutic classes for the rate of serious and fatal ADR reports per prescribing unit. Conclusion: Despite the limitations of ADR reporting and prescribing databases, the study provides a proof-of-concept for the feasibility of mapping ADR reporting onto prescribing data to create comparative safety charts that could support evidence-based decision-making around formulary choices.All medicines can cause adverse drug reactions (ADRs) leading to increases in both mortality and morbidity and incurring substantial financial costs and a significant burden on healthcare systems worldwide (1-8). The reported prevalence of ADRs in primary care is 8.3%, one fifth of which are preventable (9). Serious ADRs may be life-threatening, resulting in death or hospitalisation and may cause permanent disability or congenital abnormalities (birth defects) (10). These serious ADRs account for up to 30% of all ADRs with many being identified post-marketing (11-13). It has been shown that 30-70% of ADRs resulting in hospitalisation are considered predictable and thereby potentially preventable (11,(14)(15)(16)(17).The detection and quantification of ADRs is a key component of clinical trials prior to approval. While clinical trials are considered the bedrock for assessing drug efficacy, they are less efficient in detecting ADRs, therefore, findings from clinical trials have limited use in extrapolating risks to clinical practice (18-25). Unlike easily-detectable and wellrecognised ADRs that are often identified during pre-marketing in clinical trials, rare and late-onset ADRs remain underdetected until the post-marketing stage, during which medicines are used by a more diverse and larger population than initially intended, and for a longer period in normal clinical practice (26)(27)(28)(29)(30). Such ADRs are often undetected during clinical trials due to the relatively small number of participants studied (30-33) and the exclusion criteria, which do not usually allow for the frailest patients to participate (34). The limited trial duration and the focus on main outcomes can also hamper the detection of unpredictable (35-37) and relatively-infrequent events (38) that are rare...

show abstract

Knowledge, Attitude and Practice of Community Pharmacists towards Adverse Drug Reactions Reporting

Cited by 7 publications

References 24 publications

Impact of an educational program on community pharmacist’s preparedness to conduct pharmacist-led diabetes clinic in Saudi Arabia

Impact of an educational program on community pharmacist’s preparedness to conduct pharmacist-led diabetes clinic in Saudi Arabia

Assessment of Knowledge, Attitude, and Practice of Pharmacovigilance among Healthcare Professionals in Brazil

A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England

Contact Info

Product

Resources

About